Verici Dx plc (AIM: VRCI)
Health Care · Biotechnology · GB
£0.00
+4.44% today · -70.6% 1Y
Verici Dx plc (AIM: VRCI) operates in the Biotechnology industry within the Health Care sector. The company is valued at $12.45M.
Over the last twelve months the share price has lost 70.6%, trading between 0.00 and 0.01.
Tweenvest scores Verici Dx plc across four factors: quality 37/100, value 44/100. Its strongest factor is value.
VRCI price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $12.45M
- Revenue (TTM)
- $3.52M
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 1.19
- 52-week high
- £0.01
- 52-week low
- £0.00
- Avg volume (3M)
- —
- Shares outstanding
- 3.97B
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Algorae Pharmaceuticals LimitedASX: 1AI | $12.70M | AU$0.01 | +12.50% |
| America Great HealthOTCPK: AAGH | $12.69M | $0.00 | +100.00% |
| GT Biopharma, Inc.NasdaqCM: GTBP | $12.68M | $7.03 | +5.24% |
| Cerenome, Inc.NasdaqCM: CNSY | $12.45M | $1.64 | -6.29% |
| Clal Biotechnology Industries Ltd.TASE: CBI | $12.34M | ₪0.24 | +2.52% |
| Synlogic, Inc.OTCPK: SYBX | $12.25M | $1.00 | -9.09% |
| NextCell Pharma ABOM: NXTCL | $12.20M | Skr0.96 | -5.53% |
| Radiopharm Theranostics LimitedASX: RAD | $12.07M | AU$0.00 | -20.00% |
Figures last refreshed Oct 18, 2026.